By By Times of Israel Staff
Israeli BioPharm Company Protalix Can Produce The ZMapp Ebola Drug
Although the ZMapp Ebola drug, which proved effective on infected American aid workers, has run out, Israeli company Protalix says it can produce more, if needed.
September 12, 2014